Literature DB >> 16368968

Trypanosoma cruzi infection induces proliferation of vascular smooth muscle cells.

Ghada S Hassan1, Shankar Mukherjee, Fnu Nagajyothi, Louis M Weiss, Stefka B Petkova, Cecilia J de Almeida, Huan Huang, Mahalia S Desruisseaux, Boumediene Bouzahzah, Richard G Pestell, Chris Albanese, George J Christ, Michael P Lisanti, Herbert B Tanowitz.   

Abstract

Trypanosoma cruzi infection causes cardiomyopathy and vasculopathy. Previous studies have demonstrated that infection of human umbilical vein endothelial and smooth muscle cells resulted in activation of extracellular signal-regulated kinase (ERK). In the present study, smooth muscle cells were infected with trypomastigotes, and immunoblot analysis revealed an increase in the expression of cyclin D1 and proliferating cell nuclear antigen (PCNA), important mediators of smooth muscle cell proliferation. Interestingly, after infection, the expression of caveolin-1 was reduced in both human umbilical vein endothelial cells and smooth muscle cells. Immunoblot and immunohistochemical analyses of lysates of carotid arteries obtained from infected mice revealed increased expression of PCNA, cyclin D1, its substrate, phospho-Rb (Ser780), and phospho-ERK1/2. The expression of the cyclin-dependent kinase inhibitor p21(Cip1/Waf1), caveolin-1, and caveolin-3 was reduced in carotid arteries obtained from infected mice. There was an increase in the abundance of pre-pro-endothelin-1 mRNA in the carotid artery and aorta from infected mice. The ET(A) receptor was also elevated in infected arteries. ERK activates endothelin-1, which in turn exerts positive feedback activating ERK, and cyclin D1 is a downstream target of both endothelin-1 and ERK. There was significant incorporation of bromodeoxyuridine into smooth muscle cell DNA when treatment was with conditioned medium obtained from infected endothelial cells. Taken together, these data suggest that T. cruzi infection stimulates smooth muscle cell proliferation and is likely a result of the upregulation of the ERK-cyclin D1-endothelin-1 pathway.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16368968      PMCID: PMC1346667          DOI: 10.1128/IAI.74.1.152-159.2006

Source DB:  PubMed          Journal:  Infect Immun        ISSN: 0019-9567            Impact factor:   3.441


  46 in total

1.  Cytokine gene expression of endothelial cells infected with Trypanosoma cruzi.

Authors:  H B Tanowitz; J P Gumprecht; D Spurr; T M Calderon; M C Ventura; C Raventos-Suarez; S Kellie; S M Factor; V B Hatcher; M Wittner
Journal:  J Infect Dis       Date:  1992-09       Impact factor: 5.226

2.  Endothelial function is preserved in Chagas' heart disease patients without heart failure.

Authors:  Fernanda M Consolim-Colombo; Heno F Lopes; Eliana A Rosetto; Marcelo C Rubira; José Augusto S Barreto-Filho; Antonio Cláudio A Baruzzi; Nazareth N Rocha; Charles Mady; Maria Claudia Irigoyen; Eduardo M Krieger
Journal:  Endothelium       Date:  2004 Sep-Dec

Review 3.  Coronary microvascular abnormalities in Chagas' disease.

Authors:  M A Rossi; S G Ramos
Journal:  Am Heart J       Date:  1996-07       Impact factor: 4.749

Review 4.  Parasite persistence in the aetiology of Chagas disease.

Authors:  R L Tarleton
Journal:  Int J Parasitol       Date:  2001-05-01       Impact factor: 3.981

Review 5.  The role of endothelin in the pathogenesis of Chagas' disease.

Authors:  S B Petkova; H Huang; S M Factor; R G Pestell; B Bouzahzah; L A Jelicks; L M Weiss; S A Douglas; M Wittner; H B Tanowitz
Journal:  Int J Parasitol       Date:  2001-05-01       Impact factor: 3.981

6.  Trypanosoma cruzi infection activates extracellular signal-regulated kinase in cultured endothelial and smooth muscle cells.

Authors:  Shankar Mukherjee; Huan Huang; Stefka B Petkova; Chris Albanese; Richard G Pestell; Vicki L Braunstein; George J Christ; Murray Wittner; Michael P Lisanti; Joan W Berman; Louis M Weiss; Herbert B Tanowitz
Journal:  Infect Immun       Date:  2004-09       Impact factor: 3.441

7.  Inhibition of muscle differentiation by trypanosoma cruzi.

Authors:  K S Rowin; H B Tanowitz; M Wittner; H T Nguyen; B Nadal-Ginard
Journal:  Proc Natl Acad Sci U S A       Date:  1983-10       Impact factor: 11.205

8.  Capillary damage in skeletal muscle in advanced Chagas' disease patients.

Authors:  Sonia H Torres; Héctor J Finol; María Montes de Oca; Francia Vásquez; Juan J Puigbó; José G Loyo
Journal:  Parasitol Res       Date:  2004-06-15       Impact factor: 2.289

9.  Coronary vascular reactivity is abnormal in patients with Chagas' heart disease.

Authors:  F W Torres; H Acquatella; J A Condado; R Dinsmore; I F Palacios
Journal:  Am Heart J       Date:  1995-05       Impact factor: 4.749

10.  Endothelin-1 as a putative modulator of erectile dysfunction. II. Calcium mobilization in cultured human corporal smooth muscle cells.

Authors:  W Zhao; G J Christ
Journal:  J Urol       Date:  1995-10       Impact factor: 7.450

View more
  21 in total

Review 1.  Chagas heart disease: report on recent developments.

Authors:  Fabiana S Machado; Linda A Jelicks; Louis V Kirchhoff; Jamshid Shirani; Fnu Nagajyothi; Shankar Mukherjee; Randin Nelson; Christina M Coyle; David C Spray; Antonio C Campos de Carvalho; Fangxia Guan; Cibele M Prado; Michael P Lisanti; Louis M Weiss; Susan P Montgomery; Herbert B Tanowitz
Journal:  Cardiol Rev       Date:  2012 Mar-Apr       Impact factor: 2.644

Review 2.  The vasculature in chagas disease.

Authors:  Cibele M Prado; Linda A Jelicks; Louis M Weiss; Stephen M Factor; Herbert B Tanowitz; Marcos A Rossi
Journal:  Adv Parasitol       Date:  2011       Impact factor: 3.870

Review 3.  Endothelin-1 and its role in the pathogenesis of infectious diseases.

Authors:  Brandi D Freeman; Fabiana S Machado; Herbert B Tanowitz; Mahalia S Desruisseaux
Journal:  Life Sci       Date:  2014-04-26       Impact factor: 5.037

4.  Rapamycin Treatment Reduces Acute Myocarditis Induced by Trypanosoma cruzi Infection.

Authors:  Thabata L A Duque; Cynthia M Cascabulho; Gabriel M Oliveira; Andrea Henriques-Pons; Rubem F S Menna-Barreto
Journal:  J Innate Immun       Date:  2019-12-04       Impact factor: 7.349

5.  Trypanosoma cruzi infection results in an increase in intracellular cholesterol.

Authors:  Christopher Johndrow; Randin Nelson; Herbert Tanowitz; Louis M Weiss; Fnu Nagajyothi
Journal:  Microbes Infect       Date:  2014-01-28       Impact factor: 2.700

Review 6.  Recent developments in the interactions between caveolin and pathogens.

Authors:  Fabiana S Machado; Nilda E Rodriguez; Daniel Adesse; Luciana R Garzoni; Lisia Esper; Michael P Lisanti; Robert D Burk; Chris Albanese; Koenraad Van Doorslaer; Louis M Weiss; Fnu Nagajyothi; Joshua D Nosanchuk; Mary E Wilson; Herbert B Tanowitz
Journal:  Adv Exp Med Biol       Date:  2012       Impact factor: 2.622

7.  Expression of cytokines and chemokines and microvasculature alterations of the tongue from patients with chronic Chagas' disease.

Authors:  Sanivia A de Lima Pereira; Viviane O Severino; Narayane L M Kohl; Denise B R Rodrigues; Polyanna M Alves; Juliana T Clemente-Napimoga; Marlene A dos Reis; Vicente P A Teixeira; Marcelo H Napimoga
Journal:  Parasitol Res       Date:  2009-06-10       Impact factor: 2.289

8.  Trypanosoma cruzi infection of cultured adipocytes results in an inflammatory phenotype.

Authors:  Fnu Nagajyothi; Mahalia S Desruisseaux; Niranjan Thiruvur; Louis M Weiss; Vicki L Braunstein; Chris Albanese; Mauro M Teixeira; Cecilia J de Almeida; Michael P Lisanti; Philipp E Scherer; Herbert B Tanowitz
Journal:  Obesity (Silver Spring)       Date:  2008-09       Impact factor: 5.002

Review 9.  Perspectives on the Trypanosoma cruzi-host cell receptor interactions.

Authors:  Fernando Villalta; Julio Scharfstein; Anthony W Ashton; Kevin M Tyler; Fangxia Guan; Shankar Mukherjee; Maria F Lima; Sandra Alvarez; Louis M Weiss; Huan Huang; Fabiana S Machado; Herbert B Tanowitz
Journal:  Parasitol Res       Date:  2009-03-13       Impact factor: 2.289

Review 10.  Current understanding of immunity to Trypanosoma cruzi infection and pathogenesis of Chagas disease.

Authors:  Fabiana S Machado; Walderez O Dutra; Lisia Esper; Kenneth J Gollob; Mauro M Teixeira; Stephen M Factor; Louis M Weiss; Fnu Nagajyothi; Herbert B Tanowitz; Nisha J Garg
Journal:  Semin Immunopathol       Date:  2012-10-18       Impact factor: 9.623

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.